Advantage of post-operative oral administration of UFT (Tegafur and Uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC)

By Tanaka F.   Miyahara R.   Ohtake Y.   Yanagihara K.   Fukuse T.   Hitomi S.   Wada H.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 3, 1998-09 ,pp. : 256-262

Elsevier

Access to resources Recommend Favorite

Advantage of postoperative oral administration of UFT (Tegafur and Uracil) for completely resected p-Stage I-IIIa non-small cell lung cancer (NSCLC)

By Maggi G.   Ruffini E.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 3, 1998-09 ,pp. : 263-264

Elsevier

Access to resources Recommend Favorite

Postoperative adjuvant chemotherapy with PVM (Cisplatin+Vindesine+Mitomycin C) and UFT (Uracil+Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial

By Wada H.   Miyahara R.   Tanaka F.   Hitomi S.  

European Journal of Cardio-Thoracic Surgery, Vol. 15, Iss. 4, 1999-04 ,pp. : 438-443

Elsevier

Access to resources Recommend Favorite

Oral Administration of Uracil-Tegafur (UFT) Inhibits Liver Micrometastasis of Human Colon Cancer in an Orthotopic Nude Mouse Model and Its Early Detection System

By Takahashi Yutaka  

Surgery Today, Vol. 34, Iss. 10, 2004-10 ,pp. : 855-859

Springer Publishing Company

Access to resources Recommend Favorite

Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy

By Voltolini L.   Luzzi L.   Ghiribelli C.   Paladini P.   Di Bisceglie M.   Gotti G.  

European Journal of Cardio-Thoracic Surgery, Vol. 20, Iss. 6, 2001-12 ,pp. : 1106-1112

Elsevier

Access to resources Recommend Favorite